tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Financial Statements

95 Followers

Petros Pharmaceuticals Financial Overview

Petros Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-6.205; its P/E ratio is -0.07; Petros Pharmaceuticals is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.39M$ 1.67M$ 1.99M$ 2.52M$ -2.12M
Gross Profit$ 1.06M$ 1.27M$ 1.48M$ 1.97M$ -3.00M
EBIT$ -3.58M$ -4.42M$ -2.46M$ -1.66M$ -6.41M
EBITDA$ -2.83M$ -3.59M$ -1.64M$ -833.15K$ -5.65M
Net Income Common Stockholders$ -8.03M$ -4.89M$ -2.55M$ -1.52M$ -7.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.08M$ 17.97M$ 7.38M$ 8.32M$ 9.40M
Total Assets$ 30.31M$ 38.91M$ 28.73M$ 30.57M$ 32.42M
Total Debt$ 8.01M$ 8.39M$ 8.76M$ 9.12M$ 9.48M
Net Debt$ -3.07M$ -9.58M$ 1.37M$ 799.87K$ 77.78K
Total Liabilities$ 19.62M$ 31.86M$ 15.78M$ 15.12M$ 15.72M
Stockholders Equity$ 9.79M$ 6.93M$ 12.90M$ 15.45M$ 16.70M
Cash Flow-
Free Cash Flow$ -1.13M$ -4.05M$ -572.07K$ -748.36K$ -1.60M
Operating Cash Flow$ -1.13M$ -4.05M$ -572.07K$ -748.36K$ -1.60M
Investing Cash Flow-----
Financing Cash Flow$ -1.12M$ 14.63M$ -363.20K$ -357.83K$ -185.06K
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History

Petros Pharmaceuticals Debt to Assets

Petros Pharmaceuticals Cash Flow

Petros Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis